CTGLF1 Activators
CTGLF1 activators are a class of chemical agents that are specifically designed to modulate the biological pathway involving the protein referred to as CTGLF1. This protein is a component of a complex network of intracellular processes that are essential for the normal functioning of various cellular mechanisms. The precise molecular function of CTGLF1 is rooted in cellular signaling pathways where it may act as a pivotal intermediary, influencing the behavior of cells in response to internal and external stimuli. CTGLF1 activators, therefore, are compounds that can enhance the activity of this protein, potentially leading to an upregulation of the pathways in which CTGLF1 is involved. The design of these molecules is typically informed by an in-depth understanding of the protein's structure, as well as the nature of its interactions with other molecular entities within the cell.
The development of CTGLF1 activators often involves a multidisciplinary approach that combines elements of biochemistry, molecular biology, and organic chemistry. At the molecular level, these activators may bind to the CTGLF1 protein at specific sites, inducing a conformational change that increases its activity or stabilizes its active form. This binding may mimic the effects of natural ligands or alter the protein's interaction with other cellular components, resulting in an enhanced functional output of the CTGLF1 pathway. The synthesis of CTGLF1 activators is a careful and precise operation, requiring the creation of molecules that not only have the ability to interact with the protein in a desired manner but also possess suitable chemical properties to ensure stability, solubility, and specificity. The investigation into the behavior of these activators within biological systems provides valuable insights into the fundamental cellular processes governed by CTGLF1 and contributes to a broader understanding of the molecular mechanics at play within living organisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cAMP levels, which can activate PKA. Activation of PKA is known to enhance the functional activity of CTGLF1 by phosphorylating it or associated regulatory proteins, thus promoting CTGLF1's role in cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a potent activator of protein kinase C (PKC), which can phosphorylate and thereby enhance the functional activity of CTGLF1 or its associated signaling proteins, influencing CTGLF1's involvement in signal transduction pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially leading to the activation of calcium-dependent kinases that could phosphorylate and activate CTGLF1 or proteins in its signaling pathway. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain kinases, potentially leading to a shift in cellular signaling balance that enhances the activation of CTGLF1 by reducing inhibitory phosphorylation events. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, potentially leading to downstream activation of kinases that enhance the functional activity of CTGLF1 in signaling pathways such as those involved in cell migration and angiogenesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can lead to the activation of downstream components like AKT. The inhibition of PI3K can lead to a compensatory response that activates CTGLF1 indirectly via altered signaling dynamics. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, potentially leading to the activation of CTGLF1 through calcium-dependent signaling pathways that are crucial for various cellular processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, potentially leading to an altered balance in MAPK/ERK signaling, which can indirectly lead to the activation of CTGLF1 as part of a compensatory cellular response to the inhibited pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, potentially leading to a shift in signaling that favors the activation of CTGLF1 as the cell compensates for the inhibited p38 MAPK pathway. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor, which might lead to selective activation of CTGLF1 pathways by lifting the inhibition exerted by specific kinases on processes in which CTGLF1 is involved. | ||||||